SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (2203)2/6/2000 2:22:00 PM
From: Hank  Read Replies (1) of 5582
 
If pleconaril inhibits 96% of all rhinoviruses, then they must have changed it's chemical structure from it's original form to make it more effective. When pleconaril was originally discovered, it only inhibited 50% of the known rhinoviral serotypes in the lab. This I know to be a fact because I consulted with the people who discovered this drug some 9 years ago when they first began to work with it. I know they were trying for a long time to synthesize an analog that would inhibit 100%. I guess they finally found one. At any rate, that doesn't negate my original point which is that not all rhinoviruses are necessarily equally sensitive to the same treatments. No matter how many facts you throw at me to give the illusion that you understand the science behind this, you can not prove otherwise.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News